Controlling T‑Cell Activation with Synthetic Dendritic Cells Using the Multivalency Effect

• Roel Hammink,
• Subhra Mandal,
• Loek J. Eggermont,
• Marco Nooteboom,
• Peter H. G. M. Willems,
• Jurjen Tel,
• Alan E. Rowan,
• Carl G. Figdor,
• Kerstin G. Blank

Affiliations

Roel Hammink

Department of Molecular Materials, Institute for Molecules and Materials, Radboud University, Nijmegen, The Netherlands

Subhra Mandal

‡Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University, Nijmegen, The Netherlands

Loek J. Eggermont

‡Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University, Nijmegen, The Netherlands

Marco Nooteboom

§Department of Biochemistry, Radboud Institute for Molecular Life Sciences, Radboud University, Nijmegen, The Netherlands

Peter H. G. M. Willems

§Department of Biochemistry, Radboud Institute for Molecular Life Sciences, Radboud University, Nijmegen, The Netherlands

Jurjen Tel

‡Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University, Nijmegen, The Netherlands

Alan E. Rowan

Department of Molecular Materials, Institute for Molecules and Materials, Radboud University, Nijmegen, The Netherlands

Carl G. Figdor

‡Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University, Nijmegen, The Netherlands

Kerstin G. Blank

Department of Molecular Materials, Institute for Molecules and Materials, Radboud University, Nijmegen, The Netherlands